The neuroprotective role of Humanin in Alzheimer's disease: The molecular effects DOI Creative Commons
Saad Misfer Alqahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

European Journal of Pharmacology, Год журнала: 2025, Номер unknown, С. 177510 - 177510

Опубликована: Март 1, 2025

Humanin (HN) is an endogenous micropeptide also known as a mitochondria-derived peptide. It has neuroprotective effect against Alzheimer's disease (AD) and other neurodegenerative diseases by improving hippocampal acetylcholine attenuating the development of oxidative stress associated neurotoxicity. HN protects neuron from toxic effects amyloid beta (Aβ). regarded biomarker mitochondrial stress. Interestingly, aging reduces brain expression HN, leading to cognitive impairment elevating risk neurodegeneration, including AD. However, in old subjects AD patients, circulating levels increase compensatory mechanism reduce neurodegeneration dysfunction Conversely, studies demonstrated reduction These findings indicated controversial points regarding precise mechanistic role Therefore, aim this review was discuss exact neuropathology molecular mechanisms

Язык: Английский

New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy DOI
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 95, С. 102209 - 102209

Опубликована: Янв. 28, 2024

Язык: Английский

Процитировано

17

Pathogenesis of Parkinson’s Disease DOI
Bin Xiao, Zhidong Zhou, Yinxia Chao

и другие.

Neurologic Clinics, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

2

Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator DOI Creative Commons

Naif H. Ali,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Molecular Medicine, Год журнала: 2023, Номер 29(1)

Опубликована: Окт. 25, 2023

Abstract Autophagy is an explicit cellular process to deliver dissimilar cytoplasmic misfolded proteins, lipids and damaged organelles the lysosomes for degradation elimination. The mechanistic target of rapamycin (mTOR) main negative regulator autophagy. mTOR pathway involved in regulating neurogenesis, synaptic plasticity, neuronal development excitability. Exaggerated activity associated with temporal lobe epilepsy, genetic acquired experimental epilepsy. In particular, complex 1 (mTORC1) mainly epileptogenesis. investigation autophagy’s involvement epilepsy has recently been conducted, focusing on critical role rapamycin, autophagy inducer, reducing severity induced seizures animal model studies. induction could be innovative therapeutic strategy managing Despite protective against epileptogenesis its status epilepticus (SE) perplexing might beneficial or detrimental. Therefore, present review aims revise possible

Язык: Английский

Процитировано

30

The Molecular Pathway of p75 Neurotrophin Receptor (p75NTR) in Parkinson’s Disease: The Way of New Inroads DOI

Naif H. Ali,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Molecular Neurobiology, Год журнала: 2023, Номер 61(5), С. 2469 - 2480

Опубликована: Окт. 28, 2023

Язык: Английский

Процитировано

28

Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel DOI
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb

и другие.

Ageing Research Reviews, Год журнала: 2023, Номер 92, С. 102119 - 102119

Опубликована: Ноя. 4, 2023

Язык: Английский

Процитировано

25

Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective DOI Creative Commons

Naif H. Ali,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2023, Номер 28(2)

Опубликована: Окт. 17, 2023

Alzheimer's disease (AD) is a heterogeneous neurodegenerative with multifaceted neuropathological disorders. AD characterized by intracellular accumulation of phosphorylated tau proteins and extracellular deposition amyloid beta (Aβ). Various protease enzymes, including neprilysin (NEP), are concerned the degradation clearance Aβ. Indeed, defective neuronal pathway due to dysfunction enzymes might be possible mechanism for Aβ subsequent progression neuropathology. NEP one most imperative metalloproteinase involved in This review aimed highlight role inhibitors AD. The combination sacubitril valsartan which called angiotensin receptor blocker inhibitor (ARNI) may produce beneficial deleterious effects on increase risk inhibition clearance, brain bradykinin (BK) natriuretic peptides (NPs), augment pathogenesis These verdicts come from animal model studies, though they not applied humans. However, clinical studies revealed promising safety findings regarding use ARNI. Moreover, increases various neuroprotective inflammation, glucose homeostasis nerve conduction. Also, inhibit dipeptidyl peptidase 4 (DPP4) expression, ameliorating insulin glucagon-like peptide 1 (GLP-1) levels. proposed that have protective effect against development increasing GLP-1, neuropeptide Y (NPY) substance P, BK. Preclinical recommended this regard.

Язык: Английский

Процитировано

23

Defective autophagy and autophagy activators in myasthenia gravis: a rare entity and unusual scenario DOI
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Majid S. Jabir

и другие.

Autophagy, Год журнала: 2024, Номер 20(7), С. 1473 - 1482

Опубликована: Фев. 12, 2024

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction (NMJ) that results from autoantibodies against nicotinic acetylcholine receptors (nAchRs) at NMJs. These are mainly originated autoreactive B cells bind and destroy nAchRs NMJs preventing nerve impulses activating end-plates skeletal muscle. Indeed, immune dysregulation plays a crucial role in pathogenesis MG. Autoreactive increased MG due to defect central peripheral tolerance mechanisms. As well, T augmented diversion regulatory (T

Язык: Английский

Процитировано

11

Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue DOI Creative Commons
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Molecular Neurobiology, Год журнала: 2024, Номер 61(9), С. 7092 - 7108

Опубликована: Фев. 17, 2024

Abstract Parkinson’s disease (PD) is a progressive neurodegenerative of the brain due to degeneration dopaminergic neurons in substantia nigra (SN). Glycogen synthase kinase 3 beta (GSK-3β) implicated pathogenesis PD. Therefore, purpose present review was revise mechanistic role GSK-3β PD neuropathology, and how inhibitors affect neuropathology. GSK-3 conserved threonine/serine protein that intricate regulation cellular anabolic catabolic pathways by modulating glycogen synthase. Over-expression also interconnected with development different diseases. However, underlying mechanism neuropathology not fully clarified. induces triggering mitochondrial dysfunction oxidative stress SN. NF-κB NLRP3 inflammasome are activated response dysregulated leading neuronal injury. Higher expression early stages might contribute reduction neuroprotective brain-derived neurotrophic factor (BDNF). Thus, may be effective reducing inflammatory disorders which associated

Язык: Английский

Процитировано

11

The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon DOI
Hayder M. Al‐kuraishy,

Sadiq M. Al‐Hamash,

Majid S. Jabir

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 94, С. 102200 - 102200

Опубликована: Янв. 17, 2024

Язык: Английский

Процитировано

10

The role of statins in amyotrophic lateral sclerosis: protective or not? DOI Creative Commons
Hayder M. Al‐kuraishy, Majid S. Jabir, Ghassan M. Sulaiman

и другие.

Frontiers in Neuroscience, Год журнала: 2024, Номер 18

Опубликована: Июнь 5, 2024

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of motor neurons characterized by muscle weakness, twitching, and wasting. ALS regarded as the third-most frequent disease, subsequent to Alzheimer's (AD) Parkinson's (PD). The World Health Organization (WHO) in 2007 declared that prolonged use statins may induce development ALS-like syndrome increase risk. Subsequently, different studies have implicated pathogenesis ALS. In contrast, results from preclinical clinical highlighted protective role against neuropathology. Recently, meta-analyses systematic reviews illustrated no association between long-term These findings controversial points regarding effects on neuroprotective progression be mediated regulating dyslipidemia inflammatory changes. However, mechanism for induction neuropathology related dysregulation liver X receptor signaling (LXR) reduction cholesterol, which has effect Nevertheless, exact was not fully elucidated. Therefore, this narrative review aims discuss

Язык: Английский

Процитировано

10